Medigen Vaccine Biologics (6547) — Tangible Net Worth Ratio
Medigen Vaccine Biologics (6547) has a Tangible Net Worth Ratio of 100.0% as of June 2026. This metric is calculated by deducting intangible assets (NT$0.00) from net assets (NT$3.56 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Also explore Medigen Vaccine Biologics net asset momentum to track the company's year-over-year net asset growth rate.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Medigen Vaccine Biologics Tangible Net Worth Ratio (2012–2025)
This chart shows how Medigen Vaccine Biologics's Tangible Net Worth Ratio has changed across 14 annual periods from 2012 to 2025. As of June 2026, the ratio stands at 100.0%, reflecting net assets of NT$3.56 Billion with intangible assets of NT$0.00 TWD. For live market cap and overall valuation, see how much is Medigen Vaccine Biologics worth.
Annual Tangible Net Worth Ratio for Medigen Vaccine Biologics (2012–2025)
The table below presents the year-by-year Tangible Net Worth Ratio for Medigen Vaccine Biologics from 2012 to 2025, covering 14 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. Explore Medigen Vaccine Biologics capex to cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
| Year | Tangible NW Ratio | Net Assets (TWD) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 99.4% | NT$3.48 Billion | NT$21.14 Million | NT$3.93 Billion | ▲ +0.2 pp |
| 2024 | 99.2% | NT$3.85 Billion | NT$29.38 Million | NT$4.36 Billion | ▲ +0.2 pp |
| 2023 | 99.0% | NT$3.85 Billion | NT$38.30 Million | NT$6.09 Billion | ▼ -0.1 pp |
| 2022 | 99.1% | NT$5.03 Billion | NT$45.36 Million | NT$7.35 Billion | ▲ +0.2 pp |
| 2021 | 98.9% | NT$4.68 Billion | NT$52.98 Million | NT$5.30 Billion | ▲ +0.8 pp |
| 2020 | 98.1% | NT$3.14 Billion | NT$60.01 Million | NT$3.49 Billion | ▲ +2.6 pp |
| 2019 | 95.5% | NT$1.37 Billion | NT$61.81 Million | NT$2.28 Billion | ▼ -0.2 pp |
| 2018 | 95.7% | NT$1.61 Billion | NT$69.69 Million | NT$2.18 Billion | ▲ +0.8 pp |
| 2017 | 94.9% | NT$1.52 Billion | NT$77.66 Million | NT$2.14 Billion | ▲ +0.4 pp |
| 2016 | 94.5% | NT$1.47 Billion | NT$80.53 Million | NT$1.82 Billion | ▲ +1.0 pp |
| 2015 | 93.5% | NT$1.34 Billion | NT$87.67 Million | NT$1.65 Billion | ▲ +2.3 pp |
| 2014 | 91.2% | NT$1.08 Billion | NT$95.29 Million | NT$1.21 Billion | ▲ +11.2 pp |
| 2013 | 80.0% | NT$457.94 Million | NT$91.69 Million | NT$477.40 Million | ▲ +56.8 pp |
| 2012 | 23.1% | NT$128.00 Million | NT$98.38 Million | NT$150.15 Million | — |